We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

147 hedge funds and large institutions have $267M invested in Vaxart in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $8.24M

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

20% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 41

4% more funds holding

Funds holding: 141147 (+6)

4.2% more ownership

Funds ownership: 29.86%34.05% (+4.2%)

10% less capital invested

Capital invested by funds: $297M → $267M (-$29.9M)

Holders
147
Holders Change
+6
Holders Change %
+4.26%
% of All Funds
2.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
49
Reduced
41
Closed
23
Calls
$12.9M
Puts
$8.24M
Net Calls
+$4.63M
Net Calls Change
-$937K

VXRT Hedge Fund Activity: Q4 2021 in Review

147 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2021, worth a combined $267M — down 10% from $297M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new VXRT positions and 23 closed out — a net gain of 6 holders — while 49 added to existing stakes and 41 trimmed.

The largest buyer was State Street, adding an estimated $17.4M. The largest seller was GMT Capital, exiting entirely with an estimated $4.49M sold.

  • 147 institutional investors held Vaxart (VXRT) as of Q4 2021, up from 141 in Q3 2021.
  • Funds reported $267M of Vaxart stock for Q4 2021, down 10% quarter-over-quarter.
  • 29 funds opened new Vaxart positions in Q4 2021 and 23 closed out, a net change of +6 holders.
  • The largest Vaxart buyer in Q4 2021 was State Street, an estimated $17.4M added.
  • The largest Vaxart seller in Q4 2021 was GMT Capital, an estimated $4.49M sold.

Based on aggregated 13F filings for Q4 2021.